Follow the 피플바이오 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 피플바이오 has published 4 insider filings. Market capitalisation: €13.9bn. The latest transaction was reported on 7 July 2026 (Other). Among the most active insiders: 피플바이오. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
PeopleBio 是一家在XKRX市场上市的医疗保健和制药领域的公司。它专注于开发疾病诊断和治疗的创新解决方案。